Central Hospital Saint Quentin
14
6
6
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 14 trials
100.0%
+13.5% vs industry average
7%
1 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Amikacin Liposome Inhalation Suspension for Treatment of Mycobacterium Xenopi Pulmonary Infection
Role: collaborator
A Procalcitonin-based Algorithm in Adhesion-related Small Bowel Obstruction
Role: collaborator
Identification of Predictive Biomarkers for Immune-Related Adverse Events (irAEs) in Patients Undergoing Immune CheckPoint Inhibitors (ICPI) Treatment
Role: collaborator
Possibilities of Use MRI-Guided Laser Interstitial Thermal Therapy in Medically Intractable Tremor
Role: collaborator
The Benefits of Hippotherapy for Patients With Parkinson's Disease of 75 Years
Role: lead
Impact of Virtual Reality on the Quality of Life of Oncology Patients
Role: lead
4D CT Scan Versus 3D CT Scan Concerning Cardiac Dosimetry Assesment for Left Sided Breast Cancers Radiotherapy
Role: lead
Screening for Postpartum Depression and Associated Risk Factors Among Women Who Deliver in Four Hospital in France During the COVID-19 Epidemic
Role: collaborator
Efficacy and Safety of iStent Inject and Inject W in the Management of Primary Open-angle Glaucoma
Role: collaborator
S-ICD French Cohort Study (HONEST)
Role: collaborator
Giant Cell Arteritis: Comparison Between Two Standardized Corticosteroids Tapering
Role: collaborator
Association Between Cerebral Arterial Vascular Flow and Sleep Apnea in Neurodegenerative Alterations
Role: lead
Management of Parapneumonic Pleurisy Guided by an Early Pleural Ultrasound
Role: lead
SEINIOR:Quality of Life and Breast Cancer in Older Women
Role: lead
All 14 trials loaded